0.009901
0.000000
0.001675
0.000000
0.019612
0.000000
0.000000
0.000000
0.016232
0.00000
0.00000
0.00000
Lalonde, J.M.
Zhao, B.
Smith, W.W.
Janson, C.A.
Desjarlais, R.L.
Tomaszek, T.A.
Carr, T.J.
Thompson, S.K.
Yamashita, D.S.
Veber, D.F.
Abdel-Mequid, S.S.
http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic
4
90.00
99.60
90.00
101.000
50.990
62.480
C3 H7 N O2
89.093
y
ALANINE
L-peptide linking
C6 H15 N4 O2 1
175.209
y
ARGININE
L-peptide linking
C4 H8 N2 O3
132.118
y
ASPARAGINE
L-peptide linking
C4 H7 N O4
133.103
y
ASPARTIC ACID
L-peptide linking
C3 H7 N O2 S
121.158
y
CYSTEINE
L-peptide linking
C5 H10 N2 O3
146.144
y
GLUTAMINE
L-peptide linking
C5 H9 N O4
147.129
y
GLUTAMIC ACID
L-peptide linking
C2 H5 N O2
75.067
y
GLYCINE
peptide linking
C6 H10 N3 O2 1
156.162
y
HISTIDINE
L-peptide linking
H2 O
18.015
WATER
non-polymer
C6 H13 N O2
131.173
y
ISOLEUCINE
L-peptide linking
C6 H13 N O2
131.173
y
LEUCINE
L-peptide linking
C6 H15 N2 O2 1
147.195
y
LYSINE
L-peptide linking
C9 H11 N O2
165.189
y
PHENYLALANINE
L-peptide linking
C5 H9 N O2
115.130
y
PROLINE
L-peptide linking
C22 H36 N2 O5
408.532
CARBOBENZYLOXY-(L)-LEUCINYL-(L)LEUCINYL METHOXYMETHYLKETONE
non-polymer
C3 H7 N O3
105.093
y
SERINE
L-peptide linking
C4 H9 N O3
119.119
y
THREONINE
L-peptide linking
C11 H12 N2 O2
204.225
y
TRYPTOPHAN
L-peptide linking
C9 H11 N O3
181.189
y
TYROSINE
L-peptide linking
C5 H11 N O2
117.146
y
VALINE
L-peptide linking
US
J.Med.Chem.
JMCMAR
0151
0022-2623
41
4567
4576
10.1021/jm980249f
9804696
Use of papain as a model for the structure-based design of cathepsin K inhibitors: crystal structures of two papain-inhibitor complexes demonstrate binding to S'-subsites.
1998
10.2210/pdb1bqi/pdb
pdb_00001bqi
1.000000
0.000000
0.000000
0.000000
1.000000
0.000000
0.000000
0.000000
1.000000
0.00000
0.00000
0.00000
287
1
AREA DETECTOR
1995-06
SIEMENS
MONOCHROMATOR
M
x-ray
1
1.5418
1.0
1.5418
ROTATING ANODE
SIEMENS
METHOXYMETHYLKETONE BOUND NON-COVALENTLY IN S'-SUBSITE
23449.346
PAPAIN
1
nat
polymer
408.532
CARBOBENZYLOXY-(L)-LEUCINYL-(L)LEUCINYL METHOXYMETHYLKETONE
1
syn
non-polymer
18.015
water
42
nat
water
no
no
IPEYVDWRQKGAVTPVKNQGSCGSCWAFSAVVTIEGIIKIRTGNLNQYSEQELLDCDRRSYGCNGGYPWSALQLVAQYGI
HYRNTYPYEGVQRYCRSREKGPYAAKTDGVRQVQPYNQGALLYSIANQPVSVVLQAAGKDFQLYRGGIFVGPCGNKVDHA
VAAVGYGPNYILIKNSWGTGWGENGYIRIKRGTGNSYGVCGLYTSSFYPVKN
IPEYVDWRQKGAVTPVKNQGSCGSCWAFSAVVTIEGIIKIRTGNLNQYSEQELLDCDRRSYGCNGGYPWSALQLVAQYGI
HYRNTYPYEGVQRYCRSREKGPYAAKTDGVRQVQPYNQGALLYSIANQPVSVVLQAAGKDFQLYRGGIFVGPCGNKVDHA
VAAVGYGPNYILIKNSWGTGWGENGYIRIKRGTGNSYGVCGLYTSSFYPVKN
A
polypeptide(L)
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
papaya
Carica
sample
3649
Carica papaya
2
3.3
63.62
8.5
pH 8.5
diffrn_source
pdbx_database_status
pdbx_unobs_or_zero_occ_atoms
database_2
pdbx_initial_refinement_model
pdbx_unobs_or_zero_occ_atoms
struct_ref_seq_dif
struct_site
repository
Initial release
Version format compliance
Version format compliance
Advisory
Data collection
Other
Advisory
Database references
Derived calculations
Refinement description
1
0
1999-08-16
1
1
2008-03-24
1
2
2011-07-13
1
3
2018-03-07
1
4
2023-08-09
_diffrn_source.source
_pdbx_database_status.process_site
_database_2.pdbx_DOI
_database_2.pdbx_database_accession
_struct_ref_seq_dif.details
_struct_site.pdbx_auth_asym_id
_struct_site.pdbx_auth_comp_id
_struct_site.pdbx_auth_seq_id
Y
BNL
1998-08-16
REL
SBA
CARBOBENZYLOXY-(L)-LEUCINYL-(L)LEUCINYL METHOXYMETHYLKETONE
HOH
water
1PIP
PDB ENTRY 1PIP
PDB
experimental model
SBA
300
2
SBA
SBA
300
A
HOH
400
3
HOH
HOH
400
A
HOH
404
3
HOH
HOH
404
A
HOH
405
3
HOH
HOH
405
A
HOH
406
3
HOH
HOH
406
A
HOH
409
3
HOH
HOH
409
A
HOH
410
3
HOH
HOH
410
A
HOH
411
3
HOH
HOH
411
A
HOH
413
3
HOH
HOH
413
A
HOH
414
3
HOH
HOH
414
A
HOH
415
3
HOH
HOH
415
A
HOH
416
3
HOH
HOH
416
A
HOH
418
3
HOH
HOH
418
A
HOH
421
3
HOH
HOH
421
A
HOH
422
3
HOH
HOH
422
A
HOH
426
3
HOH
HOH
426
A
HOH
429
3
HOH
HOH
429
A
HOH
435
3
HOH
HOH
435
A
HOH
436
3
HOH
HOH
436
A
HOH
441
3
HOH
HOH
441
A
HOH
443
3
HOH
HOH
443
A
HOH
444
3
HOH
HOH
444
A
HOH
450
3
HOH
HOH
450
A
HOH
451
3
HOH
HOH
451
A
HOH
453
3
HOH
HOH
453
A
HOH
454
3
HOH
HOH
454
A
HOH
455
3
HOH
HOH
455
A
HOH
456
3
HOH
HOH
456
A
HOH
457
3
HOH
HOH
457
A
HOH
468
3
HOH
HOH
468
A
HOH
469
3
HOH
HOH
469
A
HOH
484
3
HOH
HOH
484
A
HOH
487
3
HOH
HOH
487
A
HOH
490
3
HOH
HOH
490
A
HOH
501
3
HOH
HOH
501
A
HOH
502
3
HOH
HOH
502
A
HOH
504
3
HOH
HOH
504
A
HOH
505
3
HOH
HOH
505
A
HOH
506
3
HOH
HOH
506
A
HOH
507
3
HOH
HOH
507
A
HOH
508
3
HOH
HOH
508
A
HOH
510
3
HOH
HOH
510
A
HOH
511
3
HOH
HOH
511
A
ILE
1
n
1
ILE
1
A
PRO
2
n
2
PRO
2
A
GLU
3
n
3
GLU
3
A
TYR
4
n
4
TYR
4
A
VAL
5
n
5
VAL
5
A
ASP
6
n
6
ASP
6
A
TRP
7
n
7
TRP
7
A
ARG
8
n
8
ARG
8
A
GLN
9
n
9
GLN
9
A
LYS
10
n
10
LYS
10
A
GLY
11
n
11
GLY
11
A
ALA
12
n
12
ALA
12
A
VAL
13
n
13
VAL
13
A
THR
14
n
14
THR
14
A
PRO
15
n
15
PRO
15
A
VAL
16
n
16
VAL
16
A
LYS
17
n
17
LYS
17
A
ASN
18
n
18
ASN
18
A
GLN
19
n
19
GLN
19
A
GLY
20
n
20
GLY
20
A
SER
21
n
21
SER
21
A
CYS
22
n
22
CYS
22
A
GLY
23
n
23
GLY
23
A
SER
24
n
24
SER
24
A
CYS
25
n
25
CYS
25
A
TRP
26
n
26
TRP
26
A
ALA
27
n
27
ALA
27
A
PHE
28
n
28
PHE
28
A
SER
29
n
29
SER
29
A
ALA
30
n
30
ALA
30
A
VAL
31
n
31
VAL
31
A
VAL
32
n
32
VAL
32
A
THR
33
n
33
THR
33
A
ILE
34
n
34
ILE
34
A
GLU
35
n
35
GLU
35
A
GLY
36
n
36
GLY
36
A
ILE
37
n
37
ILE
37
A
ILE
38
n
38
ILE
38
A
LYS
39
n
39
LYS
39
A
ILE
40
n
40
ILE
40
A
ARG
41
n
41
ARG
41
A
THR
42
n
42
THR
42
A
GLY
43
n
43
GLY
43
A
ASN
44
n
44
ASN
44
A
LEU
45
n
45
LEU
45
A
ASN
46
n
46
ASN
46
A
GLN
47
n
47
GLN
47
A
TYR
48
n
48
TYR
48
A
SER
49
n
49
SER
49
A
GLU
50
n
50
GLU
50
A
GLN
51
n
51
GLN
51
A
GLU
52
n
52
GLU
52
A
LEU
53
n
53
LEU
53
A
LEU
54
n
54
LEU
54
A
ASP
55
n
55
ASP
55
A
CYS
56
n
56
CYS
56
A
ASP
57
n
57
ASP
57
A
ARG
58
n
58
ARG
58
A
ARG
59
n
59
ARG
59
A
SER
60
n
60
SER
60
A
TYR
61
n
61
TYR
61
A
GLY
62
n
62
GLY
62
A
CYS
63
n
63
CYS
63
A
ASN
64
n
64
ASN
64
A
GLY
65
n
65
GLY
65
A
GLY
66
n
66
GLY
66
A
TYR
67
n
67
TYR
67
A
PRO
68
n
68
PRO
68
A
TRP
69
n
69
TRP
69
A
SER
70
n
70
SER
70
A
ALA
71
n
71
ALA
71
A
LEU
72
n
72
LEU
72
A
GLN
73
n
73
GLN
73
A
LEU
74
n
74
LEU
74
A
VAL
75
n
75
VAL
75
A
ALA
76
n
76
ALA
76
A
GLN
77
n
77
GLN
77
A
TYR
78
n
78
TYR
78
A
GLY
79
n
79
GLY
79
A
ILE
80
n
80
ILE
80
A
HIS
81
n
81
HIS
81
A
TYR
82
n
82
TYR
82
A
ARG
83
n
83
ARG
83
A
ASN
84
n
84
ASN
84
A
THR
85
n
85
THR
85
A
TYR
86
n
86
TYR
86
A
PRO
87
n
87
PRO
87
A
TYR
88
n
88
TYR
88
A
GLU
89
n
89
GLU
89
A
GLY
90
n
90
GLY
90
A
VAL
91
n
91
VAL
91
A
GLN
92
n
92
GLN
92
A
ARG
93
n
93
ARG
93
A
TYR
94
n
94
TYR
94
A
CYS
95
n
95
CYS
95
A
ARG
96
n
96
ARG
96
A
SER
97
n
97
SER
97
A
ARG
98
n
98
ARG
98
A
GLU
99
n
99
GLU
99
A
LYS
100
n
100
LYS
100
A
GLY
101
n
101
GLY
101
A
PRO
102
n
102
PRO
102
A
TYR
103
n
103
TYR
103
A
ALA
104
n
104
ALA
104
A
ALA
105
n
105
ALA
105
A
LYS
106
n
106
LYS
106
A
THR
107
n
107
THR
107
A
ASP
108
n
108
ASP
108
A
GLY
109
n
109
GLY
109
A
VAL
110
n
110
VAL
110
A
ARG
111
n
111
ARG
111
A
GLN
112
n
112
GLN
112
A
VAL
113
n
113
VAL
113
A
GLN
114
n
114
GLN
114
A
PRO
115
n
115
PRO
115
A
TYR
116
n
116
TYR
116
A
ASN
117
n
117
ASN
117
A
GLN
118
n
118
GLN
118
A
GLY
119
n
119
GLY
119
A
ALA
120
n
120
ALA
120
A
LEU
121
n
121
LEU
121
A
LEU
122
n
122
LEU
122
A
TYR
123
n
123
TYR
123
A
SER
124
n
124
SER
124
A
ILE
125
n
125
ILE
125
A
ALA
126
n
126
ALA
126
A
ASN
127
n
127
ASN
127
A
GLN
128
n
128
GLN
128
A
PRO
129
n
129
PRO
129
A
VAL
130
n
130
VAL
130
A
SER
131
n
131
SER
131
A
VAL
132
n
132
VAL
132
A
VAL
133
n
133
VAL
133
A
LEU
134
n
134
LEU
134
A
GLN
135
n
135
GLN
135
A
ALA
136
n
136
ALA
136
A
ALA
137
n
137
ALA
137
A
GLY
138
n
138
GLY
138
A
LYS
139
n
139
LYS
139
A
ASP
140
n
140
ASP
140
A
PHE
141
n
141
PHE
141
A
GLN
142
n
142
GLN
142
A
LEU
143
n
143
LEU
143
A
TYR
144
n
144
TYR
144
A
ARG
145
n
145
ARG
145
A
GLY
146
n
146
GLY
146
A
GLY
147
n
147
GLY
147
A
ILE
148
n
148
ILE
148
A
PHE
149
n
149
PHE
149
A
VAL
150
n
150
VAL
150
A
GLY
151
n
151
GLY
151
A
PRO
152
n
152
PRO
152
A
CYS
153
n
153
CYS
153
A
GLY
154
n
154
GLY
154
A
ASN
155
n
155
ASN
155
A
LYS
156
n
156
LYS
156
A
VAL
157
n
157
VAL
157
A
ASP
158
n
158
ASP
158
A
HIS
159
n
159
HIS
159
A
ALA
160
n
160
ALA
160
A
VAL
161
n
161
VAL
161
A
ALA
162
n
162
ALA
162
A
ALA
163
n
163
ALA
163
A
VAL
164
n
164
VAL
164
A
GLY
165
n
165
GLY
165
A
TYR
166
n
166
TYR
166
A
GLY
167
n
167
GLY
167
A
PRO
168
n
168
PRO
168
A
ASN
169
n
169
ASN
169
A
TYR
170
n
170
TYR
170
A
ILE
171
n
171
ILE
171
A
LEU
172
n
172
LEU
172
A
ILE
173
n
173
ILE
173
A
LYS
174
n
174
LYS
174
A
ASN
175
n
175
ASN
175
A
SER
176
n
176
SER
176
A
TRP
177
n
177
TRP
177
A
GLY
178
n
178
GLY
178
A
THR
179
n
179
THR
179
A
GLY
180
n
180
GLY
180
A
TRP
181
n
181
TRP
181
A
GLY
182
n
182
GLY
182
A
GLU
183
n
183
GLU
183
A
ASN
184
n
184
ASN
184
A
GLY
185
n
185
GLY
185
A
TYR
186
n
186
TYR
186
A
ILE
187
n
187
ILE
187
A
ARG
188
n
188
ARG
188
A
ILE
189
n
189
ILE
189
A
LYS
190
n
190
LYS
190
A
ARG
191
n
191
ARG
191
A
GLY
192
n
192
GLY
192
A
THR
193
n
193
THR
193
A
GLY
194
n
194
GLY
194
A
ASN
195
n
195
ASN
195
A
SER
196
n
196
SER
196
A
TYR
197
n
197
TYR
197
A
GLY
198
n
198
GLY
198
A
VAL
199
n
199
VAL
199
A
CYS
200
n
200
CYS
200
A
GLY
201
n
201
GLY
201
A
LEU
202
n
202
LEU
202
A
TYR
203
n
203
TYR
203
A
THR
204
n
204
THR
204
A
SER
205
n
205
SER
205
A
SER
206
n
206
SER
206
A
PHE
207
n
207
PHE
207
A
TYR
208
n
208
TYR
208
A
PRO
209
n
209
PRO
209
A
VAL
210
n
210
VAL
210
A
LYS
211
n
211
LYS
211
A
ASN
212
n
212
ASN
212
A
author_defined_assembly
1
monomeric
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
1_555
x,y,z
identity operation
0.0000000000
0.0000000000
0.0000000000
A
O
GLY
109
A
O
GLY
109
A
N
VAL
210
A
N
VAL
210
A
O
VAL
130
A
O
VAL
130
A
N
ALA
163
A
N
ALA
163
A
O
ALA
162
A
O
ALA
162
A
N
LYS
174
A
N
LYS
174
A
O
ILE
171
A
O
ILE
171
A
N
ILE
189
A
N
ILE
189
1
A
CG
ARG
59
A
CG
ARG
59
0
Y
1
A
CD
ARG
59
A
CD
ARG
59
0
Y
1
A
NE
ARG
59
A
NE
ARG
59
0
Y
1
A
CZ
ARG
59
A
CZ
ARG
59
0
Y
1
A
NH1
ARG
59
A
NH1
ARG
59
0
Y
1
A
NH2
ARG
59
A
NH2
ARG
59
0
Y
1
A
CD
GLN
73
A
CD
GLN
73
0
Y
1
A
OE1
GLN
73
A
OE1
GLN
73
0
Y
1
A
NE2
GLN
73
A
NE2
GLN
73
0
Y
1
A
CG
GLN
77
A
CG
GLN
77
0
Y
1
A
CD
GLN
77
A
CD
GLN
77
0
Y
1
A
OE1
GLN
77
A
OE1
GLN
77
0
Y
1
A
NE2
GLN
77
A
NE2
GLN
77
0
Y
1
A
CD
ARG
98
A
CD
ARG
98
0
Y
1
A
NE
ARG
98
A
NE
ARG
98
0
Y
1
A
CZ
ARG
98
A
CZ
ARG
98
0
Y
1
A
NH1
ARG
98
A
NH1
ARG
98
0
Y
1
A
NH2
ARG
98
A
NH2
ARG
98
0
Y
1
A
CD
ARG
145
A
CD
ARG
145
0
Y
1
A
NE
ARG
145
A
NE
ARG
145
0
Y
1
A
CZ
ARG
145
A
CZ
ARG
145
0
Y
1
A
NH1
ARG
145
A
NH1
ARG
145
0
Y
1
A
NH2
ARG
145
A
NH2
ARG
145
0
Y
1
A
ARG
59
0.265
SIDE CHAIN
1
3.74
0.50
120.30
124.04
A
A
A
NE
CZ
NH2
ARG
ARG
ARG
59
59
59
N
1
3.61
0.50
120.30
123.91
A
A
A
NE
CZ
NH2
ARG
ARG
ARG
93
93
93
N
1
3.63
0.50
120.30
123.93
A
A
A
NE
CZ
NH2
ARG
ARG
ARG
98
98
98
N
1
3.66
0.50
120.30
123.96
A
A
A
NE
CZ
NH2
ARG
ARG
ARG
145
145
145
N
1
A
PRO
15
-47.43
157.38
1
A
ASN
64
-115.23
57.41
1
A
VAL
75
-66.25
6.36
1
A
GLN
77
-71.46
-77.07
1
A
TYR
78
-75.83
-84.12
1
A
PRO
87
-47.77
159.83
1
A
CYS
95
-64.26
78.28
1
A
ARG
96
-75.85
35.47
1
A
SER
97
-62.21
-81.35
1
A
GLU
99
-62.44
0.24
1
A
TYR
144
-48.74
162.01
1
A
ARG
145
-169.76
25.58
1
A
ASP
158
-134.08
-69.30
1
A
SER
176
-105.02
57.76
1
A
CYS
200
59.06
-0.87
1
A
LEU
202
-40.19
-11.41
1
A
SER
205
-162.84
117.48
PARHCSDX.PRO
TOPHCSDX.PR
26.4
DISORDERED SIDE-CHAINS HAVE THEIR OCCUPANCIES SET TO ZERO IN THE ENTRY, RESIDUES 59, 73, 77, 98, 145
0.306
0.217
0.217
2.5
10.0
1174
11372
8.3
80.0
RANDOM
100000
0.1
1
GROUP RESTRAINED
THROUGHOUT
2.0
MOLECULAR REPLACEMENT
PDB ENTRY 1PIP
2.5
10.0
42
1705
30
0
1633
0.011
1.595
24.85
1.441
0.31
0.283
2.61
47
649
8
6.2
53.0
2.5
10.
1BQI
11412
2.0
0.137
1
5.9
3.6
91
0.37
2.54
2.64
1.5
2.9
91
data collection
XENGEN
data reduction
XENGEN
model building
X-PLOR
3.1
refinement
X-PLOR
3.1
data scaling
XENGEN
phasing
X-PLOR
3.1
USE OF PAPAIN AS A MODEL FOR THE STRUCTURE-BASED DESIGN OF CATHEPSIN K INHIBITORS. CRYSTAL STRUCTURES OF TWO PAPAIN INHIBITOR COMPLEXES DEMONSTRATE BINDING TO S'-SUBSITES.
1
N
N
2
N
N
3
N
N
A
TRP
7
A
TRP
7
HELX_P
A
LYS
10
A
LYS
10
5
1
4
A
CYS
25
A
CYS
25
HELX_P
A
ARG
41
A
ARG
41
1
2
17
A
GLU
50
A
GLU
50
HELX_P
A
CYS
56
A
CYS
56
1
3
7
A
PRO
68
A
PRO
68
HELX_P
A
GLN
77
A
GLN
77
1
4
10
A
ARG
98
A
ARG
98
HELX_P
A
LYS
100
A
LYS
100
5
5
3
A
ALA
120
A
ALA
120
HELX_P
A
ILE
125
A
ILE
125
1
6
6
A
LYS
139
A
LYS
139
HELX_P
A
LEU
143
A
LEU
143
1
7
5
A
VAL
199
A
VAL
199
HELX_P
A
GLY
201
A
GLY
201
5
8
3
disulf
2.036
A
CYS
22
A
SG
CYS
22
1_555
A
CYS
63
A
SG
CYS
63
1_555
disulf
2.049
A
CYS
56
A
SG
CYS
56
1_555
A
CYS
95
A
SG
CYS
95
1_555
disulf
2.032
A
CYS
153
A
SG
CYS
153
1_555
A
CYS
200
A
SG
CYS
200
1_555
HYDROLASE
HYDROLASE, SULFHYDRYL PROTEINASE, PAPAIN
A
GLY
151
A
GLY
151
1
A
PRO
152
A
PRO
152
-0.48
PAPA1_CARPA
UNP
1
1
P00784
MAMIPSISKLLFVAICLFVYMGLSFGDFSIVGYSQNDLTSTERLIQLFESWMLKHNKIYKNIDEKIYRFEIFKDNLKYID
ETNKKNNSYWLGLNVFADMSNDEFKEKYTGSIAGNYTTTELSYEEVLNDGDVNIPEYVDWRQKGAVTPVKNQGSCGSCWA
FSAVVTIEGIIKIRTGNLNEYSEQELLDCDRRSYGCNGGYPWSALQLVAQYGIHYRNTYPYEGVQRYCRSREKGPYAAKT
DGVRQVQPYNEGALLYSIANQPVSVVLEAAGKDFQLYRGGIFVGPCGNKVDHAVAAVGYGPNYILIKNSWGTGWGENGYI
RIKRGTGNSYGVCGLYTSSFYPVKN
134
345
1BQI
1
212
P00784
A
1
1
212
1
GLU
conflict
GLN
47
1BQI
A
P00784
UNP
180
47
1
GLU
conflict
GLN
118
1BQI
A
P00784
UNP
251
118
1
GLU
conflict
GLN
135
1BQI
A
P00784
UNP
268
135
2
4
anti-parallel
anti-parallel
anti-parallel
anti-parallel
A
GLY
109
A
GLY
109
A
VAL
113
A
VAL
113
A
SER
206
A
SER
206
A
VAL
210
A
VAL
210
A
VAL
130
A
VAL
130
A
VAL
133
A
VAL
133
A
ALA
160
A
ALA
160
A
GLY
167
A
GLY
167
A
TYR
170
A
TYR
170
A
LYS
174
A
LYS
174
A
TYR
186
A
TYR
186
A
LYS
190
A
LYS
190
CATALYTIC TRIAD
Author
3
BINDING SITE FOR RESIDUE SBA A 300
A
SBA
300
Software
5
A
CYS
25
A
CYS
25
3
1_555
A
HIS
159
A
HIS
159
3
1_555
A
ASN
175
A
ASN
175
3
1_555
A
GLN
142
A
GLN
142
5
1_555
A
TRP
177
A
TRP
177
5
1_555
A
GLY
180
A
GLY
180
5
1_555
A
TRP
181
A
TRP
181
5
1_555
A
HOH
511
C
HOH
5
1_555
5
C 1 2 1